← ANALYSTS · TIPRANKS
Albert Lowe · Craig-Hallum
Hits
41%
45 of 110 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+8.2%
Over a year after the rating, TipRanks’ measure
Our companies rated now
9
Buy / hold / sell: 9 / 0 / 0
Upside of the analyst’s targets
+261.0%
Average over 6 current targets, to the last price
The market’s answer to the ratings
+1.5%
Day-0 move against SPY in the rating’s direction, average over 2 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Sep 30on TipRanks 09:10 | SPRBIWMSpruce Biosciences · $119M | Reiterated | Buy | $140 | +253.1% | +3.0%next day −8.0% · 5 days −10.5% | ↗ |
| Sep 29on TipRanks 07:15 | RZLTIWMRezolute · $377M | Upgrade | Buy | $4.00 → $7.00+75.0% | +95.5% | −2.0%next day +1.4% · 5 days +3.7% | ↗ |
| Sep 23on TipRanks Sep 24 02:30 | CMPXIWMCompass Therapeutics · $158M | Reiterated | Buy | $15.00 → $8.00−46.7% | +830.2% | −4.9%next day −2.9% · 5 days −10.4% | ↗ |
| Jul 14on TipRanks Jul 15 16:35 | LCTXIWMLineage Therap · $232M | Reiterated | Buy | — | — | +0.5%next day −0.4% · 5 days −6.1% | ↗ |
| Jul 6on TipRanks 16:35 | IRDIWMOpus Genetics · $337M | Reiterated | Buy | — | — | 0.0%next day +1.5% · 5 days −12.6% | ↗ |
| Jun 22on TipRanks 09:45 | PVLAIWMPalvella Therapeutics · $1.8B | Reiterated | Buy | $205 | +70.4% | +5.4%next day +1.3% · 5 days +30.7% | ↗ |
| Jun 16on TipRanks 09:15 | SABSIWMSAB Biotherapeutics · $236M | Reiterated | Buy | $6.00 | +137.2% | −5.6%next day +6.7% · 5 days +6.9% | ↗ |
| May 15on TipRanks 09:35 | NGNEIWMNeurogene · $479M | Reiterated | Buy | $65.00 | +179.6% | −3.4%next day −6.1% · 5 days −8.0% | ↗ |
| Jan 23on TipRanks 09:40 | ELDNIWMEledon Pharmaceuticals · $184M | Reiterated | Buy | — | — | −4.1%next day +2.8% · 5 days +2.4% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗